GeneThera, Inc.

70 articles about GeneThera, Inc.

• GeneThera Inc. Enters into an exclusive real estate agreement with Cushman & Wakefield related to the ZIDAS project

  10/12/2021

  GeneThera, Inc. (OTCMKT: GTHR) announced today that it has entered into an exclusive agreement with Cushman & Wakefield (NYSE:CWK) to identify land sites and warehouse buildings in the Denver area in connection with the development of GeneThera Zoonotic Disease Alert Shield (ZIDAS) surveillance network.

• GeneThera Inc. Expands Its Operation in the United Kingdom

  5/18/2021

  GeneThera is pleased to announce that it has incorporated a subsidiary in the United Kingdom. GeneThera Robotics Ltd, a majority owned subsidiary based in England, will be responsible for UK and International Operations.

• GeneThera enters into a collaboration agreement with an International Construction Advisor Company to build a network of zoonotic diseases laboratory facilities

  4/27/2021

  GeneThera announced today that it has entered into a partnership agreement with Cumming Corporation, a privately held international project consulting firm, specialized in the healthcare sector company.

• GeneThera, Inc. Secures Huge Facilities To Expand Technology Platforms

  1/26/2016

• GeneThera, Inc. Issues Comments On The First International Research Symposium On Map And Crohn's Disease.

  9/30/2015

• GeneThera, Inc. Appoints Two New Members On Its Board Of Directors

  4/21/2015

• GeneThera, Inc. Enters Into Exclusive Collaboration Agreement With Hudson Robotics

  3/4/2015

• GeneThera, Inc. Overview On MAP Contamination In Milk And Infant Formula: Present Status And How To Improve It

  2/4/2015

• GeneThera, Inc. Acquires Applied Genetics, S.A.

  1/25/2012

• GeneThera, Inc. Finalizes License and Research Agreement With Two Leading Italian Universities; Agreement Represents Key Step in Effort to Commercialize Diagnostic and Therapeutic Solutions for Johne's Disease

  9/22/2009

• GeneThera, Inc. Announces Plans to Add Therapeutic Testing Component to Johne's Disease Diagnostic Program

  8/25/2009

• GeneThera, Inc. Announces Plans to Add Therapeutic Testing Component to Johne's Disease Diagnostic Program

  8/25/2009

• GeneThera, Inc. Retains Pfeiffer High Investor Relations

  7/23/2009

• GeneThera, Inc. Extends its Reach Overseas

  6/16/2009

• GeneThera, Inc. Updates Its Shareholders and Investing Public

  5/26/2009

• GeneThera, Inc. to Attend Western Veterinary Conference in Las Vegas

  2/13/2009

• GeneThera, Inc.'s E. Coli Vaccine Featured on CBS, Channel 4 News In Denver, Colorado

  2/10/2009

• GeneThera, Inc. Issues February Letter to Shareholders and Updates Activities

  2/9/2009

• Dr. Antonio Milici of GeneThera, Inc. Nominated for National Advisory Committee on Meat & Poultry

  1/30/2009

• GeneThera, Inc. Reveals New Corporate Logo and Packaging Supplier, Stephen Gould Corporation

  1/27/2009